Department of Medicine, University of California San Diego, San Diego, California, United States of America. AI 36214
PLoS One. 2010 Aug 19;5(8):e12284. doi: 10.1371/journal.pone.0012284.
The study aim is to estimate sensitivity and specificity of anal cytology for histologic HSIL in analyses adjusted for the imperfect biopsy reference standard.
Retrospective cohort study of an anal dysplasia screening program for HIV infected adults. We estimated the prevalence of histologic HSIL by concurrent cytology category and the associated cytology ROC area. Cytology operating characteristics for HSIL were estimated and adjusted for the imperfect reference standard by 3 methodologies. The study cohort included 261 patients with 3 available measures: (1) referral cytology; (2) HRA cytology; and (3) HRA directed biopsy. The prevalence of biopsy HSIL varied according to the concurrent HRA cytology result: 64.5% for HSIL or ASC-H, 12.6% for LSIL, 10.9% for ASCUS, and 6.3% for no abnormality. The cytology ROC area was 0.78. The observed prevalence of HSIL was 37% (referral cytology), 24% (HRA cytology), and 24% (HRA biopsy). Unadjusted estimates of sensitivity and specificity of cytology were 0.66 and 0.90, respectively. Adjusted estimates varied from 0.47-0.89 (sensitivity) and 0.89-1.0 (specificity).
Analysis of a single dataset yields widely different estimates of anal cytology operating characteristics that depend on difficult to verify assumptions regarding the accuracy of the imperfect reference standard.
本研究旨在估计分析调整不完善活检参考标准后,肛门细胞学对组织学 HSIL 的敏感性和特异性。
对感染 HIV 的成年人肛门发育不良筛查计划的回顾性队列研究。我们通过同时的细胞学分类来估计组织学 HSIL 的患病率,并通过相关的细胞学 ROC 面积来估计。通过 3 种方法估计了细胞学对 HSIL 的检测特性,并对不完善的参考标准进行了调整。研究队列包括 261 名患者,有 3 种可用的方法:(1)转诊细胞学;(2)HRA 细胞学;(3)HRA 定向活检。活检 HSIL 的患病率根据同时的 HRA 细胞学结果而有所不同:HSIL 或 ASC-H 为 64.5%,LSIL 为 12.6%,ASCUS 为 10.9%,无异常为 6.3%。细胞学 ROC 面积为 0.78。HSIL 的实际患病率为 37%(转诊细胞学)、24%(HRA 细胞学)和 24%(HRA 活检)。细胞学的未调整敏感性和特异性估计值分别为 0.66 和 0.90。调整后的估计值从 0.47-0.89(敏感性)和 0.89-1.0(特异性)不等。
对单个数据集的分析产生了广泛不同的肛门细胞学检测特性估计值,这些估计值取决于对不完善参考标准准确性的难以验证的假设。